BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 6, 2002
View Archived Issues
Immunex Sells Leukine For $380M In Preparation For Amgen Merger
In another step toward completing the merger of Immunex Corp. and Amgen Inc., the former on Friday said it has found a buyer for its cancer drug, Leukine. (BioWorld Today)
Read More
Trimeris Looks For New Fusion Inhibitors Through Neokimia Deal
Read More
Smart’ Thermoplastic Surgical Sutures Inserted Loosely Inside Incision Tighten Automatically
Read More
Thios Completes $15M Round To Work On Role Of Sulfation
Read More
Other News To Note
Read More
Appointments And Advancements
Read More